Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice
Open Access
- 1 January 2006
- journal article
- research article
- Published by Korean Society for Parasitology in The Korean Journal of Parasitology
- Vol. 44 (1) , 55-61
Abstract
For treating Leishmania major infection in BALB/c mice, we used thalidomide in conjunction with glucantime. Groups of mice were challenged with 5 × 103 metacyclic promastigotes of L. major subcutaneously. A week after the challenge, drug treatment was started and continued for 12 days. Thalidomide was orally administrated 30 mg/kg/day and glucantime was administrated intraperitoneally (200 mg/kg/day). It was shown that the combined therapy is more effective than single therapies with each one of the drugs since the foot pad swelling in the group of mice received thalidomide and glucantime was significantly decreased (0.9 ± 0.2 mm) compared to mice treated with either glucantime, thalidomide, or carrier alone (1.2 ± 0.25, 1.4 ± 0.3, and 1.7 ± 0.27 mm, respectively). Cytokine study showed that the effect of thalidomide was not dependent on IL-12; however, it up-regulated IFN-γ and down-regulated IL-10 production. Conclusively, thalidomide seems promising as a conjunctive therapy with antimony in murine model of visceral leishmaniasis.Keywords
This publication has 23 references indexed in Scilit:
- ThalidomideThe Lancet, 2004
- Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania majorGenes & Immunity, 2004
- Thalidomide modulation of the immune response in female B6C3F1 mice: a host resistance studyInternational Immunopharmacology, 2003
- Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatmentMemórias do Instituto Oswaldo Cruz, 2001
- Visceral Leishmaniasis in Mice Devoid of Tumor Necrosis Factor and Response to TreatmentInfection and Immunity, 2000
- Thalidomide Stimulates Splenic IgM Antibody Response and Cytotoxic T Lymphocyte Activity and Alters Leukocyte Subpopulation Numbers in Female B6C3F1 MiceToxicology and Applied Pharmacology, 2000
- Roles of Endogenous Gamma Interferon and Macrophage Microbicidal Mechanisms in Host Response to Chemotherapy in Experimental Visceral LeishmaniasisInfection and Immunity, 2000
- Response to Interferon‐γ plus Pentavalent Antimony in Indian Visceral LeishmaniasisThe Journal of Infectious Diseases, 1997
- Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.Journal of Experimental Medicine, 1996
- Effect of Treatment with Interferon- Alone in Visceral LeishmaniasisThe Journal of Infectious Diseases, 1995